BeOne Medicines AG
ONC
$315.07
$4.321.39%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 513.02M | 286.93M | 68.55M | -177.64M | -392.37M |
| Total Depreciation and Amortization | 139.45M | 131.68M | 146.31M | 180.67M | 174.55M |
| Total Amortization of Deferred Charges | 10.57M | 10.00M | 9.64M | 9.29M | 4.72M |
| Total Other Non-Cash Items | 542.01M | 508.06M | 552.41M | 519.96M | 504.95M |
| Change in Net Operating Assets | 79.78M | 190.90M | 8.48M | 38.93M | -79.84M |
| Cash from Operations | 1.28B | 1.13B | 785.39M | 571.21M | 212.02M |
| Capital Expenditure | -170.22M | -185.84M | -240.80M | -326.37M | -392.49M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -29.50M | -90.32M | -90.63M | -89.67M | -67.97M |
| Cash from Investing | -199.72M | -276.16M | -331.43M | -416.03M | -460.46M |
| Total Debt Issued | 1.06B | 1.08B | 765.38M | 765.38M | 806.24M |
| Total Debt Repaid | -910.97M | -1.08B | -854.02M | -853.32M | -905.80M |
| Issuance of Common Stock | 156.80M | 196.28M | 185.83M | 121.52M | 93.94M |
| Repurchase of Common Stock | -24.20M | -24.20M | -24.20M | -24.20M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -14.49M | -14.49M |
| Other Financing Activities | 877.76M | 883.56M | 885.00M | 0.00 | 3.00M |
| Cash from Financing | 1.16B | 1.06B | 958.00M | 9.39M | -2.62M |
| Foreign Exchange rate Adjustments | 75.86M | 60.02M | -14.85M | 3.59M | -25.79M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.32B | 1.97B | 1.40B | 168.16M | -276.85M |